MRNS Annual Working Capital
$124.62 M
-$102.74 M-45.19%
31 December 2023
Summary:
As of January 23, 2025, MRNS annual working capital is $124.62 million, with the most recent change of -$102.74 million (-45.19%) on December 31, 2023. During the last 3 years, it has fallen by -$10.92 million (-8.05%). MRNS annual working capital is now -45.19% below its all-time high of $227.36 million, reached on December 31, 2022.MRNS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNS Quarterly Working Capital
$22.90 M
-$23.12 M-50.24%
30 September 2024
Summary:
As of January 23, 2025, MRNS quarterly working capital is $22.90 million, with the most recent change of -$23.12 million (-50.24%) on September 30, 2024. Over the past year, it has dropped by -$101.72 million (-81.63%). MRNS quarterly working capital is now -89.93% below its all-time high of $227.36 million, reached on December 31, 2022.MRNS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.2% | -81.6% |
| 3 y3 years | -8.1% | -89.9% |
| 5 y5 years | +85.9% | -89.9% |
MRNS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.2% | +36.8% | -89.9% | at low |
| 5 y | 5-year | -45.2% | +44.7% | -89.9% | at low |
| alltime | all time | -45.2% | +2892.1% | -89.9% | +255.3% |
Marinus Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.90 M(-50.2%) |
| June 2024 | - | $46.02 M(-48.0%) |
| Mar 2024 | - | $88.52 M(-29.0%) |
| Dec 2023 | $124.62 M(-45.2%) | $124.62 M(-24.2%) |
| Sept 2023 | - | $164.49 M(-2.7%) |
| June 2023 | - | $169.01 M(-14.9%) |
| Mar 2023 | - | $198.48 M(-12.7%) |
| Dec 2022 | $227.36 M(+149.5%) | $227.36 M(+45.8%) |
| Sept 2022 | - | $155.96 M(+100.0%) |
| June 2022 | - | $77.98 M(-32.5%) |
| Mar 2022 | - | $115.53 M(+26.8%) |
| Dec 2021 | $91.11 M(-32.8%) | $91.11 M(-21.3%) |
| Sept 2021 | - | $115.81 M(+11.1%) |
| June 2021 | - | $104.23 M(-8.3%) |
| Mar 2021 | - | $113.68 M(-16.1%) |
| Dec 2020 | $135.54 M(+57.4%) | $135.54 M(+58.1%) |
| Sept 2020 | - | $85.73 M(-13.9%) |
| June 2020 | - | $99.53 M(+42.9%) |
| Mar 2020 | - | $69.67 M(-19.1%) |
| Dec 2019 | $86.10 M | $86.10 M(+164.4%) |
| Sept 2019 | - | $32.57 M(-27.6%) |
| June 2019 | - | $44.99 M(-19.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $56.20 M(-16.2%) |
| Dec 2018 | $67.03 M(+29.3%) | $67.03 M(+97.5%) |
| Sept 2018 | - | $33.94 M(-22.6%) |
| June 2018 | - | $43.85 M(-15.6%) |
| Mar 2018 | - | $51.92 M(+0.2%) |
| Dec 2017 | $51.83 M(+133.3%) | $51.83 M(+26.0%) |
| Sept 2017 | - | $41.12 M(+169.0%) |
| June 2017 | - | $15.29 M(-20.0%) |
| Mar 2017 | - | $19.11 M(-14.0%) |
| Dec 2016 | $22.21 M(-55.9%) | $22.21 M(-20.5%) |
| Sept 2016 | - | $27.94 M(-18.3%) |
| June 2016 | - | $34.21 M(-22.2%) |
| Mar 2016 | - | $43.96 M(-12.7%) |
| Dec 2015 | $50.33 M(+4.6%) | $50.33 M(+78.5%) |
| Sept 2015 | - | $28.20 M(-17.8%) |
| June 2015 | - | $34.29 M(-15.0%) |
| Mar 2015 | - | $40.35 M(-16.1%) |
| Dec 2014 | $48.11 M(+410.0%) | $48.11 M(+4.1%) |
| Sept 2014 | - | $46.21 M(+616.9%) |
| June 2014 | - | $6.45 M(-24.3%) |
| Mar 2014 | - | $8.52 M(-9.7%) |
| Dec 2013 | $9.43 M(+126.5%) | $9.43 M |
| Dec 2012 | $4.17 M | - |
FAQ
- What is Marinus Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual working capital year-on-year change?
- What is Marinus Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly working capital year-on-year change?
What is Marinus Pharmaceuticals annual working capital?
The current annual working capital of MRNS is $124.62 M
What is the all time high annual working capital for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual working capital is $227.36 M
What is Marinus Pharmaceuticals annual working capital year-on-year change?
Over the past year, MRNS annual working capital has changed by -$102.74 M (-45.19%)
What is Marinus Pharmaceuticals quarterly working capital?
The current quarterly working capital of MRNS is $22.90 M
What is the all time high quarterly working capital for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly working capital is $227.36 M
What is Marinus Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, MRNS quarterly working capital has changed by -$101.72 M (-81.63%)